These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Micro-optical prototyping of a surface acoustic wave-based point-of-care coagulation assay and first application in anticoagulated patients. Moll J; Meyer dos Santos S; Hils B; Dornuf F; Meyer dos Santos IR; Singer OC; Ferreirós N; Labocha S; Blücher A; Harder S; Krozer V Int J Clin Pharmacol Ther; 2016 Mar; 54(3):177-84. PubMed ID: 26709598 [TBL] [Abstract][Full Text] [Related]
8. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants. Ebner M; Birschmann I; Peter A; Spencer C; Härtig F; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S Crit Care; 2017 Feb; 21(1):32. PubMed ID: 28196509 [TBL] [Abstract][Full Text] [Related]
9. Optical sensing of anticoagulation status: Towards point-of-care coagulation testing. Tshikudi DM; Tripathi MM; Hajjarian Z; Van Cott EM; Nadkarni SK PLoS One; 2017; 12(8):e0182491. PubMed ID: 28771571 [TBL] [Abstract][Full Text] [Related]
10. Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography. Gantioqui J; Stevic I; Atkinson H; Chan AKC Blood Coagul Fibrinolysis; 2018 Sep; 29(6):521-527. PubMed ID: 29965810 [TBL] [Abstract][Full Text] [Related]
11. Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants. Schmitz EM; Boonen K; van den Heuvel DJ; van Dongen JL; Schellings MW; Emmen JM; van der Graaf F; Brunsveld L; van de Kerkhof D J Thromb Haemost; 2014 Oct; 12(10):1636-46. PubMed ID: 25142183 [TBL] [Abstract][Full Text] [Related]
12. Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study. Vedovati MC; Mosconi MG; Isidori F; Agnelli G; Becattini C J Thromb Thrombolysis; 2020 Feb; 49(2):251-258. PubMed ID: 31520364 [TBL] [Abstract][Full Text] [Related]
13. Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions. Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S Stroke; 2017 Sep; 48(9):2457-2463. PubMed ID: 28775134 [TBL] [Abstract][Full Text] [Related]
14. Assessing Coagulation by Rotational Thromboelastometry (ROTEM) in Rivaroxaban-Anticoagulated Blood Using Hemostatic Agents. Bar J; David A; Khader T; Mulcare M; Tedeschi C Prehosp Disaster Med; 2017 Oct; 32(5):580-587. PubMed ID: 28625215 [TBL] [Abstract][Full Text] [Related]
15. Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests. Eller T; Busse J; Dittrich M; Flieder T; Alban S; Knabbe C; Birschmann I Clin Chem Lab Med; 2014 Jun; 52(6):835-44. PubMed ID: 24406289 [TBL] [Abstract][Full Text] [Related]
16. Point-of-Care Testing of Coagulation in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants. Ebner M; Peter A; Spencer C; Härtig F; Birschmann I; Kuhn J; Wolf M; Winter N; Russo F; Zuern CS; Blumenstock G; Ziemann U; Poli S Stroke; 2015 Oct; 46(10):2741-7. PubMed ID: 26272385 [TBL] [Abstract][Full Text] [Related]
17. Determination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery. Schellings MW; Boonen K; Schmitz EM; Jonkers F; van den Heuvel DJ; Besselaar A; Hendriks JG; van de Kerkhof D Thromb Res; 2016 Mar; 139():128-34. PubMed ID: 26916310 [TBL] [Abstract][Full Text] [Related]
18. Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis. Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Rupp A; Blumenstock G; Zuern CS; Ziemann U; Poli S J Am Heart Assoc; 2018 Oct; 7(19):e009807. PubMed ID: 30371316 [TBL] [Abstract][Full Text] [Related]
19. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting. Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321 [TBL] [Abstract][Full Text] [Related]
20. Comparative Assessment of the Anticoagulant Activity of Rivaroxaban and Dabigatran in Patients With Nonvalvular Atrial Fibrillation: A Noninterventional Study. Tsantes AE; Kyriakou E; Ikonomidis I; Katogiannis K; Papadakis I; Douramani P; Kopterides P; Kapsimali V; Lekakis J; Tsangaris I; Bonovas S Medicine (Baltimore); 2016 Apr; 95(14):e3037. PubMed ID: 27057830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]